Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-30

Clinical Trial Update: A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating two low-concentration atropine sulfate eye drops for myopia, sponsored by Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atropine sulfate eye drop (low concentration) - formulation 1 (atropine sulfate)
  • Atropine sulfate eye drop (low concentration) - formulation 2 (atropine sulfate)

Snippet

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Conditions: Myopia | Phase 3 | Status: ACTIVE_NOT_RECRUITING